The global rise of antibiotic resistance in bacterial pathogens and the waning efficacy of
antibiotics urge consideration of alternative antimicrobial strategies. Phage therapy is a …

Bacteriophages, viruses that infect and replicate within bacteria, impact bacterial responses
to antibiotics in complex ways. Recent studies using lytic bacteriophages to treat bacterial …

The evolutionary arms race between phages and bacteria, where bacteria evolve resistance
to phages and phages retaliate with resistance-countering mutations, is a major driving force …

In contrast to the many reports of successful cases of personalized bacteriophage therapy,
randomized controlled trials of non-personalized bacteriophage products did not bring the …

With the increasing global threat of antibiotic resistance, there is an urgent need to develop
new effective therapies to tackle antibiotic-resistant bacterial infections. Bacteriophage …

Lower respiratory tract infections lead to significant morbidity and mortality. They are
increasingly caused by multidrug-resistant pathogens, notably in individuals with cystic …

In contrast to the many reports of successful real-world cases of personalized bacteriophage
therapy (BT), randomized controlled trials of non-personalized bacteriophage products have …

The emergence and spread of antibiotic resistance pose serious environmental and health
challenges. Attention has been drawn to phage therapy as an alternative approach to …

Clinical case of a patient with a Pseudomonas aeruginosa multidrug-resistant prosthetic
vascular graft infection which was treated with a cocktail of phages (PT07, 14/01, and PNM) …

Spread of multidrug-resistant Pseudomonas aeruginosa strains threatens to render currently
available antibiotics obsolete, with limited prospects for the development of new antibiotics …